Follow The Filings

LTRN position history

The shares of Lantern Pharma (LTRN) that HORIZON KINETICS ASSET MANAGEMENT LLC reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2023 Q1: 30,000 shares, $145K, <0.01% of portfolio, New
  2. 2023 Q2: 30,000 shares, $169K, <0.01% of portfolio
  3. 2023 Q3: 30,000 shares, $102K, <0.01% of portfolio
  4. 2023 Q4: 28,791 shares, $123K, <0.01% of portfolio, Reduce −4.0%
  5. 2024 Q1: 28,791 shares, $253K, <0.01% of portfolio
  6. 2024 Q2: 28,791 shares, $134K, <0.01% of portfolio
  7. 2024 Q3: 27,582 shares, $101K, <0.01% of portfolio, Reduce −4.2%
  8. 2024 Q4: 28,791 shares, $92K, <0.01% of portfolio, Add +4.4%
  9. 2025 Q1: 28,791 shares, $102K, <0.01% of portfolio
  10. 2025 Q2: 27,582 shares, $87K, <0.01% of portfolio, Reduce −4.2%
  11. 2025 Q3: 28,791 shares, $125K, <0.01% of portfolio, Add +4.4%
  12. 2025 Q4: 27,582 shares, $84K, <0.01% of portfolio, Reduce −4.2%
  13. 2026 Q1: 26,373 shares, $36K, <0.01% of portfolio, Reduce −4.4%
  14. 2026 Q2: 25,164 shares, $105K, <0.01% of portfolio, Reduce −4.6%
Holdings date Value % of holdings Shares Filing date All 13F holders